Generic Name: MORPHINE - ORAL Pronounced: (MORE-feen) Morphine Oral Uses
See also Warning section.
This medication is used to help relieve moderate to severe
ongoing pain (such as due to cancer). Morphine belongs to a class of drugs
known as narcotic (opiate) analgesics. It works in the brain to change how your
body feels and responds to pain.
Do not use the sustained-action form of morphine to
relieve pain that is mild or that will go away in a few days. This medication
is not for occasional ("as needed") use.
How To Use Morphine Oral
Take this medication on a regular schedule as directed by
your doctor, not as needed for sudden (breakthrough) pain. Take this drug with
or without food, usually once or twice daily (every 12 or 24 hours). If you
have nausea, it may help to take this drug with food. Ask your doctor or
pharmacist about other ways to decrease nausea (such as lying down for 1 to 2
hours with as little head movement ...
The FDA has announced a public hearing and has requested comments on the subject of the use of opioid drugs in the treatment of chronic pain.
The public hearing will be held on February 7 and 8, 2013 from 9 a.m. to 4 p.m. in Bethesda, Maryland. There will be a live Web cast of the hearing. Information on how to view the live Web cast will be located at: http://www.fda.gov/Drugs/NewsEvents/ucm326450.htm .
In addition to the public hearing, the FDA is requesting electronic or written comments on the subject. Comments will be accepted until April 8, 2013.
This is our chance to have our voices heard by the people who are making the decisions!
Some of the issues they will be considering include:
Should opioids only be prescribed for “severe” pain?
Should there be a maximum daily dose allowed for opioids?
Should there be a limit on the number of days or months a patient can be prescribed a particular opioid?
Should opioid dosage vary depending ...
The use of unicompartmental knee arthroplasty , or partial knee replacement, is still being studied in terms of effectiveness of result compared with total athroplasties. As surgeons become more familiar with the techniques and as techniques and prosthetic designs improve, implant success grows. One of the issues with partial replacements is the actual design of the implant to improve the range of motion of the joint. The authors of this study wanted to examine the alignment of the knee after surgery and insertion of the medial compartment Oxford implant (introduced in 1987 as a phase 2 implant), how well the implant survives, and how and when the implant did fail. The researchers reviewed the records of 55 implants performed in 51 patients - 4 of whom had bilateral or double knee replacements. The patients' average age was 64 years old and the average weight was 78.1 kg. The patients were assessed through the use of x-rays of the knees and the Knee Society clinical scoring instrument. T...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.